Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
December 30, 2024
Tickers
GS
LLY
MRK
NVDA
Tags
MRK
LLY
Recent Press Releases
From
Motley Fool
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
December 19, 2024
Tickers
BMY
CI
CNC
CVS
Tags
PFE
General
News
From
Benzinga
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
December 13, 2024
Tickers
AMGN
AZN
BMY
EXEL
Tags
Health Care
Media
JNJ
From
Benzinga
Novartis Touts Encouraging Data From Late-Stage Study For Fabhalta In Rare Type Of Blood Disorder
December 06, 2024
Tickers
AZN
NEWS
NVS
PTCT
Tags
PTCT
News
Top Stories
From
Benzinga
Janux Therapeutics' Prostate Cancer Trial Data Exceeds Investor Expectations: Analyst
December 03, 2024
Tickers
JANX
NEWS
NVS
Tags
Trading Ideas
Briefs
News
From
Benzinga
PTC Therapeutics Inks Licensing Pact With Novartis Worth Up To ~$3 Billion For Huntington's Program
December 02, 2024
Tickers
NEWS
NVS
PTCT
Tags
Biotech
why it's moving
Benzinga
From
Benzinga
2 Dividend Stocks to Buy and Hold Forever
December 01, 2024
Tickers
NVS
V
Tags
V
Recent Press Releases
NVS
From
Motley Fool
Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
November 21, 2024
Tickers
NEWS
NVS
Tags
Health Care
Market News
Biotech
From
Benzinga
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
November 12, 2024
Tickers
ARKG
NEWS
NVS
SDGR
Tags
SDGR
Briefs
ARKG
From
Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
Tickers
ABBV
AMGN
BIIB
BMY
Tags
Analyst Ratings
Health Care
Large Cap
From
Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
October 30, 2024
Tickers
BMY
GILD
LYEL
NEWS
Tags
Market News
LYEL
Health Care
From
Benzinga
Novartis Ag (NVS) Q3 2024 Earnings Call Transcript
October 29, 2024
Tickers
NVS
Tags
NVS
Recent Press Releases
Market News
From
Motley Fool
Novartis Q3 Earnings Beats Expectations On Strong Sales From Key Drugs, Lifts 2024 Outlook
October 29, 2024
Tickers
NEWS
NVS
Tags
Movers
Health Care
Market News
From
Benzinga
Why Is Monte Rosa Therapeutics Stock Surging On Monday?
October 28, 2024
Tickers
GLUE
NEWS
NVS
Tags
Stories That Matter
NVS
why it's moving
From
Benzinga
3 Absurdly Cheap Stocks That Pay High Dividends
October 24, 2024
Tickers
GILD
MRK
NVS
Tags
Market News
NVS
Recent Press Releases
From
Motley Fool
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
October 18, 2024
Tickers
CTLT
NEWS
NVO
NVS
Tags
CTLT
M&A
Briefs
From
Benzinga
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
October 18, 2024
Tickers
NEWS
NVS
SNY
Tags
News
General
SNY
From
Benzinga
1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move
October 17, 2024
Tickers
NVS
Tags
Recent Press Releases
NVS
Market News
From
Motley Fool
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
October 16, 2024
Tickers
ALPMF
ALPMY
APLS
NEWS
Tags
General
Top Stories
News
From
Benzinga
Looking Into Novartis's Recent Short Interest
October 14, 2024
Tickers
NVS
Tags
Short Ideas
Trading Ideas
Short Sellers
From
Benzinga
2 Magnificent Dividend Stocks to Buy and Hold Forever
October 14, 2024
Tickers
ABBV
NVS
Tags
Market News
Recent Press Releases
NVS
From
Motley Fool
Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm
October 10, 2024
Tickers
NEWS
NVS
OKUR
Tags
Initiation
Trading Ideas
Briefs
From
Benzinga
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
October 01, 2024
Tickers
AZN
LLY
NEWS
NVO
Tags
Briefs
AZN
Regulations
From
Benzinga
Incyte Downgraded - Analyst Notes Intense Competition, Particularly In Larger Markets
September 18, 2024
Tickers
INCY
NEWS
NVS
Tags
Expert Ideas
Health Care
Analyst Ratings
From
Benzinga
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
September 18, 2024
Tickers
NEWS
NVS
SNY
Tags
SNY
News
General
From
Benzinga
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
September 11, 2024
Tickers
ACET
ANIP
NEWS
NVS
Tags
Markets
Trading Ideas
ANIP
From
Benzinga
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
September 11, 2024
Tickers
APP
ASO
ATOS
CAC
Tags
SUPN
Price Target
Benzinga
From
Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
Tickers
AZN
BMY
ELVN
NEWS
Tags
RHHBY
Biotech
why it's moving
From
Benzinga
Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts
September 05, 2024
Tickers
NEWS
NVO
NVS
Tags
NVO
News
General
From
Benzinga
S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
September 05, 2024
Tickers
AI
CE
CHPT
CNM
Tags
SPGI
COLL
EVTC
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit